What the company does
Solasia Pharma K.K. develops, markets, imports, and exports pharmaceutical products and medical devices in Japan, China, South Korea, and internationally. The company offers Episil (SP-03), an oral liquid for oral mucositis/stomatitis; DARVIAS (SP-02), an antineoplastic agent injection for relapsed or refractory peripheral T-cell lymphoma; and Sancuso (SP-01) for chemotherapy-induced nausea and vomiting. It also develops SP-04, which is in a preclinical trial for chemotherapy-induced peripheral neuropathy; and SP-05, which is in a preclinical trial for colorectal cancer. The company was formerly known as JapanBridge, Inc. and changed its name to Solasia Pharma K.K. in September …
What the weekly tape is saying
4597 closed the latest completed week at 23.00 JPY. The 4-week return is -23.3% and the 12-week return is -28.1%. Trend Signal is inactive, Market Dynamics is -0.97. Setup signature: Risk-first tape with a 10/100 composite read.
A compressed read of the whole setup
The radar blends trend persistence, momentum, Market Dynamics, Relative Strength, volume confirmation, and risk control into one weekly cockpit.
Scoreboard
16-week signal tape
Price, Trend Line, and Fair Value
Weekly price context with the latest close, trend position, Fair Value gap, drawdown, and 52-week range location.
52-week price path
Price map
- Trend Line
- 30.83 JPY
- Vs Trend Line
- -25.4%
- Fair Value
- 37.56 JPY
- Vs Fair Value
- -38.8%
- 52W High
- 48.00 JPY
- 52W Low
- 21.00 JPY
- Drawdown
- -52.1%
- Range Position
- 7.4%
Returns and trend persistence
Return windows separate the latest week from short-term and medium-term follow-through.
Return windows
Trend read
- Active Streak
- 0 weeks
- 52W Active Weeks
- 13
- 52W Active Breadth
- 25.0%
- Sector Scope
- JP Healthcare
- Sector Rank
- 81 of 223
- Sector Percentile
- 64.0%
Sector and industry pulse
Peer breadth helps separate a stock-specific move from a broader group rotation.
JP Healthcare
- Tracked Peers
- 100
- 4W Rank
- - of 100
- Avg 1W
- -1.3%
- Avg 4W
- -3.4%
- Trend Breadth
- 27.0%
- Positive MD
- 28.0%
JP Drug Manufacturers - Specialty & Generic
- Tracked Peers
- 31
- 4W Rank
- 28 of 31
- Avg 1W
- -1.8%
- Avg 4W
- -10.9%
- Trend Breadth
- 9.7%
- Positive RS
- 0.0%
Pressure, Relative Strength, and expectation
Market Dynamics and Relative Strength show whether buying pressure and relative leadership are confirming the price move.
Dynamics path
Signal state
- Market Dynamics
- -0.97
- 4W MD Change
- -318.8%
- Relative Strength
- -48.65
- 4W RS Change
- -55.3%
- Expectation
- Negative
- Probability
- 39.61%
Participation and confirmation
Volume tells us whether the latest weekly move is being confirmed by unusual participation.
52-week volume profile
Volume map
- Latest Volume
- 270.3M
- 13W Average
- 281.4M
- 52W Average
- 184.5M
- Vs 13W
- 1.0x
- Vs 52W
- 1.5x
Volatility, downside weeks, and return shape
A compact risk profile shows whether the move is steady, volatile, or being driven by sharp one-week jumps.
26-week return distribution
Risk map
- 13W Volatility
- 6.7%
- 52W Volatility
- 7.5%
- Upside Weeks
- 17
- Downside Weeks
- 23
- Downside Breadth
- 44.2%
- Avg Gain / Loss
- 8.0% / -6.4%
Classification, opportunities, risks, and watch points
Top-level read across company classification, constructive evidence, caution points, and the next things that matter.
Classification
- Exchange
- JPX
- Country
- JP
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Currency
- JPY
- Market Cap
- 7.1B
Opportunity signals
- No strong opportunity cluster is confirmed yet; monitor trend and Market Dynamics.
Risk signals
- Trend Signal is inactive, so price action has not confirmed a constructive regime.
- Price is below the Trend Line, which keeps downside pressure in focus.
- Price is below Fair Value, so the market is still discounting the latest tape.
- Market Dynamics is negative, which weakens the current setup.
- The share remains more than 20% below its 52-week high.
Watch next
- Trend Line remains the key weekly regime level.
- Market Dynamics is the pressure gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Recent completed weeks
The latest weekly rows behind the report snapshot.
| Week | Close | Return | Trend | Fair Value | MD | RS | Volume | Signal |
|---|---|---|---|---|---|---|---|---|
| 12 Jun 2026 | 23.00 JPY | 0.0% | 30.83 JPY | 37.56 JPY | -0.97 | -48.65 | 270.3M | Off |
| 5 Jun 2026 | 23.00 JPY | -11.5% | 31.13 JPY | 37.70 JPY | -0.66 | -49.72 | 327.5M | Off |
| 29 May 2026 | 26.00 JPY | 0.0% | 31.47 JPY | 37.84 JPY | -0.35 | -43.65 | 393.6M | Off |
| 22 May 2026 | 26.00 JPY | -13.3% | 31.67 JPY | 37.96 JPY | -0.11 | -41.67 | 288.5M | Off |
| 15 May 2026 | 30.00 JPY | -6.2% | 31.97 JPY | 38.08 JPY | 0.44 | -31.33 | 351.8M | On |
| 8 May 2026 | 32.00 JPY | 0.0% | 32.10 JPY | 38.17 JPY | 0.81 | -28.91 | 111.7M | On |
| 1 May 2026 | 32.00 JPY | -8.6% | 32.20 JPY | 38.27 JPY | 1.12 | -25.82 | 203.7M | On |
| 24 Apr 2026 | 35.00 JPY | -7.9% | 32.30 JPY | 38.36 JPY | 1.38 | -19.85 | 360.6M | On |
| 17 Apr 2026 | 38.00 JPY | 11.8% | 32.33 JPY | 38.43 JPY | 1.34 | -11.85 | 410.8M | Off |
| 10 Apr 2026 | 34.00 JPY | 0.0% | 32.27 JPY | 38.48 JPY | 1.19 | -19.67 | 299.9M | Off |
| 3 Apr 2026 | 34.00 JPY | 3.0% | 32.27 JPY | 38.56 JPY | 1.02 | -14.71 | 248.6M | Off |
| 27 Mar 2026 | 33.00 JPY | 3.1% | 32.37 JPY | 38.65 JPY | 0.93 | -18.19 | 217.9M | Off |
| 20 Mar 2026 | 32.00 JPY | 0.0% | 32.50 JPY | 38.76 JPY | 0.88 | -21.48 | 173.2M | Off |
| 13 Mar 2026 | 32.00 JPY | -5.9% | 32.70 JPY | 38.87 JPY | 0.75 | -23.07 | 146.6M | Off |